Evidence map›Paper›PMID 35045675›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia].

H Li, T Y Wang, Y Yin, P L Wang, Z Cheng, J P Li, W Li, F Y Zhu, C C Wu, Z M Luo and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

H LiThe Second Xiangya Hospital, Central South University, Changsha 410011, China.
T Y WangInstitute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Tianjin 300020, China.
Y YinThe Second Xiangya Hospital, Central South University, Changsha 410011, China.
P L WangThe Second Xiangya Hospital, Central South University, Changsha 410011, China.
Z ChengThe Second Xiangya Hospital, Central South University, Changsha 410011, China.
J P LiChangsha Central Hospital Affiliated to Nanhua University, Changsha 410000, China.
W LiHunan People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410000, China.
F Y ZhuLoudi Central Hospital, Loudi 417000, China.
C C WuThe Second People's Hospital of Yueyang, Yueyang 414000, China.
Z M LuoXiangtan Central Hospital, Xiangtan 411100, China.
Y H ChenThe Second Hospital, University of South China, Hengyang 421000, China.
H XiaoThe First People's Hospital of Xiangtan City, Xiangtan 411100, China.
S B DengYongzhou Central Hospital, Yongzhou 425000, China.
Y Q CaoThe First Hospital of Changsha, Changsha 410000, China.
G S ZhangThe Second Xiangya Hospital, Central South University, Changsha 410011, China.
L G QiuInstitute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Tianjin 300020, China.
H L PengThe Second Xiangya Hospital, Central South University, Changsha 410011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellChinaHumansImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionMutationImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Identifiers

PMID35045675
PMCPMC8770890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.